Details for New Drug Application (NDA): 208701
✉ Email this page to a colleague
The generic ingredient in CELECOXIB is celecoxib. There are twenty-six drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
Summary for 208701
Tradename: | CELECOXIB |
Applicant: | Cadila Pharms Ltd |
Ingredient: | celecoxib |
Patents: | 0 |
Pharmacology for NDA: 208701
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 208701
Suppliers and Packaging for NDA: 208701
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CELECOXIB | celecoxib | CAPSULE;ORAL | 208701 | ANDA | REMEDYREPACK INC. | 70518-4009 | 70518-4009-0 | 100 POUCH in 1 BOX (70518-4009-0) / 1 CAPSULE in 1 POUCH (70518-4009-1) |
CELECOXIB | celecoxib | CAPSULE;ORAL | 208701 | ANDA | Cadila Pharmaceuticals Limited | 71209-054 | 71209-054-03 | 60 CAPSULE in 1 BOTTLE (71209-054-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Nov 14, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Nov 14, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Nov 14, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription